$NOTV
Inotiv, Inc.

2015 Q1 Form 10-Q Financial Statement

#000114420415031506 Filed on May 15, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $5.726M $5.912M
YoY Change -3.15% 14.66%
Cost Of Revenue $3.924M $3.900M
YoY Change 0.62% 0.05%
Gross Profit $1.802M $2.012M
YoY Change -10.44% 59.94%
Gross Profit Margin 31.47% 34.03%
Selling, General & Admin $1.636M $1.737M
YoY Change -5.81% 51.84%
% of Gross Profit 90.79% 86.33%
Research & Development $138.0K $170.0K
YoY Change -18.82% 38.21%
% of Gross Profit 7.66% 8.45%
Depreciation & Amortization $350.0K $400.0K
YoY Change -12.5% -9.09%
% of Gross Profit 19.42% 19.88%
Operating Expenses $1.774M $1.907M
YoY Change -6.97% 50.51%
Operating Profit $28.00K $105.0K
YoY Change -73.33% -1266.67%
Interest Expense $75.00K $121.0K
YoY Change -38.02% -25.77%
% of Operating Profit 267.86% 115.24%
Other Income/Expense, Net -$1.000K $4.000K
YoY Change -125.0% 33.33%
Pretax Income $151.0K -$212.0K
YoY Change -171.23% -31.83%
Income Tax $1.000K $7.000K
% Of Pretax Income 0.66%
Net Earnings $150.0K -$219.0K
YoY Change -168.49% -29.58%
Net Earnings / Revenue 2.62% -3.7%
Basic Earnings Per Share $0.02 -$0.03
Diluted Earnings Per Share -$0.01 -$0.03
COMMON SHARES
Basic Shares Outstanding 8.076M shares 7.964M shares
Diluted Shares Outstanding 8.105M shares 7.964M shares

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $540.0K $380.0K
YoY Change 42.11% 171.43%
Cash & Equivalents $536.0K $379.0K
Short-Term Investments
Other Short-Term Assets $450.0K $760.0K
YoY Change -40.79% 300.0%
Inventory $1.670M $1.507M
Prepaid Expenses $761.0K
Receivables $3.030M $2.735M
Other Receivables $720.0K $1.130M
Total Short-Term Assets $6.400M $6.517M
YoY Change -1.8% 17.19%
LONG-TERM ASSETS
Property, Plant & Equipment $15.45M $16.27M
YoY Change -5.02% -8.28%
Goodwill $1.383M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $140.0K $43.00K
YoY Change 225.58% -15.69%
Total Long-Term Assets $16.61M $17.74M
YoY Change -6.34% -7.77%
TOTAL ASSETS
Total Short-Term Assets $6.400M $6.517M
Total Long-Term Assets $16.61M $17.74M
Total Assets $23.01M $24.25M
YoY Change -5.12% -2.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.550M $3.363M
YoY Change -24.17% -8.09%
Accrued Expenses $1.300M $1.657M
YoY Change -21.54% 16.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $1.050M $4.953M
YoY Change -78.8% -10.74%
Total Short-Term Liabilities $8.750M $14.29M
YoY Change -38.78% -0.69%
LONG-TERM LIABILITIES
Long-Term Debt $4.230M
YoY Change
Other Long-Term Liabilities $50.00K
YoY Change
Total Long-Term Liabilities $4.280M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.750M $14.29M
Total Long-Term Liabilities $4.280M $0.00
Total Liabilities $13.02M $14.62M
YoY Change -10.96% 1.61%
SHAREHOLDERS EQUITY
Retained Earnings -$14.60M
YoY Change 3.36%
Common Stock $1.976M
YoY Change 5.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.980M $9.629M
YoY Change
Total Liabilities & Shareholders Equity $23.01M $24.25M
YoY Change -5.12% -2.17%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income $150.0K -$219.0K
YoY Change -168.49% -29.58%
Depreciation, Depletion And Amortization $350.0K $400.0K
YoY Change -12.5% -9.09%
Cash From Operating Activities $600.0K -$30.00K
YoY Change -2100.0% -86.36%
INVESTING ACTIVITIES
Capital Expenditures -$110.0K -$100.0K
YoY Change 10.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$110.0K -$100.0K
YoY Change 10.0% -600.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -760.0K -330.0K
YoY Change 130.3% -13.16%
NET CHANGE
Cash From Operating Activities 600.0K -30.00K
Cash From Investing Activities -110.0K -100.0K
Cash From Financing Activities -760.0K -330.0K
Net Change In Cash -270.0K -460.0K
YoY Change -41.3% -20.69%
FREE CASH FLOW
Cash From Operating Activities $600.0K -$30.00K
Capital Expenditures -$110.0K -$100.0K
Free Cash Flow $710.0K $70.00K
YoY Change 914.29% -131.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1005000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
9543000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
8128000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8076000 shares
us-gaap Depreciation And Amortization
DepreciationAndAmortization
799000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
314000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-442000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
108000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
128000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
488000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-32000 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
272000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
440000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8863000 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
93000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
730000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
48000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
45000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-8000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-243000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-122000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-180000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-542000 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
492000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-231000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-150000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
393000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
301000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
231000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
150000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
3532000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3330000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
151000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
131000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-746000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1746000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
92000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-34000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-445000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-925000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1304000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
379000 USD
us-gaap Stock Issued1
StockIssued1
USD
us-gaap Stock Issued1
StockIssued1
36000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
60000 USD
CY2014Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
295000 USD
CY2015Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
388000 USD
CY2014Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
340000 USD
CY2015Q1 us-gaap Inventory Gross
InventoryGross
1997000 USD
CY2014Q3 us-gaap Inventory Gross
InventoryGross
1863000 USD
CY2015Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
325000 USD
CY2014Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
299000 USD
CY2015Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
1280000 USD
CY2014Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1228000 USD
CY2015Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
329000 USD
CY2015Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16000 USD
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005 pure
CY2014Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16000 USD
CY2015Q1 basi Share Based Compensation Options Outstanding Issued Outside Of Stock Option Plan
ShareBasedCompensationOptionsOutstandingIssuedOutsideOfStockOptionPlan
155000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
CY2015Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
4530000 USD
CY2014Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
4526000 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1196000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
dei Trading Symbol
TradingSymbol
BASI
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
BIOANALYTICAL SYSTEMS INC
dei Entity Central Index Key
EntityCentralIndexKey
0000720154
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8076378 shares
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1386000 USD
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
5726000 USD
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
5912000 USD
CY2015Q1 us-gaap Cost Of Services
CostOfServices
3242000 USD
CY2014Q1 us-gaap Cost Of Services
CostOfServices
3330000 USD
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
682000 USD
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
570000 USD
CY2015Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3924000 USD
CY2014Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3900000 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
1802000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
2012000 USD
CY2015Q1 us-gaap Selling Expense
SellingExpense
426000 USD
CY2014Q1 us-gaap Selling Expense
SellingExpense
479000 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
138000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
170000 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1210000 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1258000 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
1774000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
1907000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
28000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
105000 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
75000 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
121000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2015Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-199000 USD
CY2014Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
200000 USD
CY2015Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
-1000 USD
CY2014Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
151000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-212000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
150000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-219000 USD
CY2015Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
-15000 USD
CY2014Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
51000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
186000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-227000 USD
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8076000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7964000 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8105000 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7964000 shares
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-2000 USD
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
2000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
161000 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
839000 USD
CY2015Q1 us-gaap Revenues
Revenues
5726000 USD
CY2014Q1 us-gaap Revenues
Revenues
5912000 USD
us-gaap Revenues
Revenues
11571000 USD
us-gaap Revenues
Revenues
12132000 USD
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
150000 USD
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-219000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
332000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-881000 USD
CY2015Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-199000 USD
CY2014Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
USD
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-319000 USD
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
USD
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-49000 USD
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-219000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
13000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-881000 USD
CY2015Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
shares
CY2014Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
shares
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
592000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
shares
CY2015Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
29000 shares
CY2014Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
64000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
CY2015Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2014Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
131000 shares
CY2014Q3 us-gaap Restructuring Reserve
RestructuringReserve
1078000 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
39000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
USD
us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
USD
CY2015Q1 us-gaap Restructuring Reserve
RestructuringReserve
1117000 USD
CY2015Q1 us-gaap Restructuring And Related Cost Expected Cost Remaining1
RestructuringAndRelatedCostExpectedCostRemaining1
800000 USD

Files In Submission

Name View Source Status
0001144204-15-031506-index-headers.html Edgar Link pending
0001144204-15-031506-index.html Edgar Link pending
0001144204-15-031506.txt Edgar Link pending
0001144204-15-031506-xbrl.zip Edgar Link pending
basi-20150331.xml Edgar Link completed
basi-20150331.xsd Edgar Link pending
basi-20150331_cal.xml Edgar Link unprocessable
basi-20150331_def.xml Edgar Link unprocessable
basi-20150331_lab.xml Edgar Link unprocessable
basi-20150331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpg16.jpg Edgar Link pending
v410129_10q.htm Edgar Link pending
v410129_ex10-1.htm Edgar Link pending
v410129_ex31-1.htm Edgar Link pending
v410129_ex31-2.htm Edgar Link pending
v410129_ex32-1.htm Edgar Link pending
v410129_ex32-2.htm Edgar Link pending